Developing an AAV-Based Gene Therapy for MYBPC3 Mutation-Associated Hypertrophic Cardiomyopathy

被引：0
|
作者：
Salameh, Therese [1 ]
Xu, Hongbin [1 ]
Duan, Hong [1 ]
Sharma, Yogeshwar [1 ]
Yedlapudi, Deepthi [1 ]
Ren, Chao [2 ]
Cao, Jingsong [1 ]
Shi, Zhong-Dong [1 ]
机构：
[1] Frontera Therapeut, Bedford, MA USA
[2] Frontera Therapeut, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
610
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [31] HYPERTROPHIC CARDIOMYOPATHY AND MYBPC3 VARIANT - A CLINICAL CASE
    Bianco, M.
    Nangeroni, G.
    Biole, C.
    Garello, L.
    Giachino, D.
    Chinaglia, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26
  • [32] Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
    Toepfer, Christopher N.
    Wakimoto, Hiroko
    Garfinkel, Amanda C.
    McDonough, Barbara
    Liao, Dan
    Jiang, Jianming
    Tai, Angela C.
    Gorham, Joshua M.
    Lunde, Ida G.
    Lun, Mingyue
    Lynch, Thomas L.
    McNamar, James W.
    Sadayappa, Sakthivel
    Redwood, Charles S.
    Watkins, Hugh C.
    Seidma, Jonathan G.
    Seidman, Christine E.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (476)
  • [33] MYBPC3 Mutations in Indian Patients With Hypertrophic Cardiomyopathy
    Wankhade, Varsha W.
    CIRCULATION RESEARCH, 2019, 125
  • [34] Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish
    Zahka, K.
    Kalidas, K.
    Simpson, M. A.
    Cross, H.
    Keller, B. B.
    Galambos, C.
    Gurtz, K.
    Patton, M. A.
    Crosby, A. H.
    HEART, 2008, 94 (10) : 1326 - 1330
  • [35] Identification of founder MYBPC3 gene mutations in hungarian patients with hypertrophic cardiomyopathy
    Tringer, A.
    Hategan, L.
    Csanyi, B.
    Borbas, J.
    Palinkas, E.
    Nagy, V.
    Hegedus, Z.
    Nagy, I.
    Forster, T.
    Sepp, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 55 - 55
  • [36] Fatal neonatal hypertrophic cardiomyopathy caused by compound heterozygous truncating MYBPC3 mutation
    S. Alsters
    L. Wong
    L. Peferoen
    H. W. M. Niessen
    H. Bikker
    M. W. Elting
    A. C. Houweling
    Netherlands Heart Journal, 2019, 27 : 282 - 283
  • [37] MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy by Dysregulating Myosin: Implications for Therapy
    Toepfer, Christopher N.
    Wakimoto, Hiroko
    Garfinkel, Amanda C.
    McDonough, Barbara
    Liao, Dan
    Jiang, Jianming
    Tai, Angela
    Gorham, Josh
    Lund, Ida G.
    Lund, Ida G.
    Lun, Mingyue
    Lynch, T. L.
    Sadayappan, S.
    Redwood, C. S.
    Watkins, H.
    Seidman, J.
    Seidman, C.
    CIRCULATION RESEARCH, 2018, 123
  • [38] AUTOSOMAL RECESSIVE TANSMISSION OF MYBPC3 MUTATION RESULTED IN MALIGNANT PHENOTPYE OF HYPERTROPHIC CARDIOMYOPATHY
    Wang Yilu
    Wang Zhimin
    Yang Qi
    Zou Yubao
    Zhang Hongju
    Yan Chaowu
    Feng Xinxing
    Chen Yi
    Zhang Yin
    Wang Jizheng
    Zhou Xianliang
    Ferhaan, Ahmad
    Hui Rutai
    Song Lei
    HEART, 2013, 99 : A34 - A35
  • [39] Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
    Ehlermann, Philipp
    Weichenhan, Dieter
    Zehelein, Jorg
    Steen, Henning
    Pribe, Regina
    Zeller, Raphael
    Lehrke, Stephanie
    Zugck, Christian
    Ivandic, Boris T.
    Katus, Hugo A.
    BMC MEDICAL GENETICS, 2008, 9
  • [40] Autosomal Recessive Transmission of MYBPC3 Mutation Results in Malignant Phenotype of Hypertrophic Cardiomyopathy
    Wang, Yilu
    Wang, Zhimin
    Yang, Qi
    Zou, Yubao
    Zhang, Hongju
    Yan, Chaowu
    Feng, Xinxing
    Chen, Yi
    Zhang, Yin
    Wang, Jizheng
    Zhou, Xianliang
    Ahmad, Ferhaan
    Hui, Rutai
    Song, Lei
    PLOS ONE, 2013, 8 (06):
12345